Supplement shopping in 2026 offers more choice than ever: hundreds of products for a single ingredient, instant delivery, reviews on everything, and prices that undercut the high street. And yet buyers are more confused than ever — because choice has grown faster than clarity, and the tools meant to help buyers decide have not kept pace with the market they are supposed to explain.

The first problem is comparison. A marketplace listing for one ingredient may offer hundreds of products, differing in dose, form, testing and price, with no standard way to compare them. Labels are designed to resist comparison: different serving sizes, different ingredient names, different ways of expressing the same amount. The buyer is left to do the arithmetic themselves, and most do not — they choose by price, by brand familiarity, or by the persuasiveness of the packaging.

The second problem is reviews. Star ratings measure popularity, satisfaction, or the effectiveness of a review-request campaign — not quality. A product with thousands of five-star reviews may be well made, or it may simply be well marketed. Written reviews are often vague, sometimes incentivised, and rarely written by people who checked the label against the research. A rating that does not explain its method is a number without meaning, and most ratings do not explain their method.

The third problem is badges. "Third-party tested", "clinically proven", "doctor formulated", "premium grade" — each phrase sounds like a certification, and none of them is one. They are marketing terms, applied by the brands themselves, with no standard behind them and no independent verification required. A badge that cannot be checked is decoration, however impressive it looks on the bottle.

The fourth problem is price. A premium bottle pays for packaging, advertising, endorsements and retail margins, none of which improves what is inside. A plain bottle sold directly to consumers may carry the same testing, the same ingredients and the same dose at half the price. Judging quality by price is judging a product by its marketing budget — and the budget is not the product.

The fifth problem is the evidence itself. Much supplement research is small, short and preliminary. A botanical studied in forty healthy adults for eight weeks tells you something — but it does not prove a product works for everyone, at any dose, for any length of time. Brands that present preliminary research as proof are overstating their case, and buyers who accept the claim at face value are buying a conclusion the evidence does not support.

So what should a buyer do? Apply the same toolkit that has always worked, with more discipline. Calculate the cost per serving. Check that every ingredient is disclosed with its amount. Compare the dose with the research. Ask for the batch certificate. Translate each claim into a question, and look for the study behind it. Keep a record of what you take, and share it with your doctor and pharmacist.

And use independent reviews that show their working. Thesupplementrating.com publishes evidence-led reviews that start with the label, check doses against research, examine testing disclosure and state their limits plainly — and its safety checklist covers the five checks that matter most before you buy. A review of a gelatin-based formula shows the method in practice: label first, dose second, evidence third, verdict last.

More choice should make buying easier. Until the market provides better tools for comparing products, the buyers who do it well will be the ones who check the evidence themselves — not the ones who trust the packaging.